The New York Times defended its reporting on Elon Musk ‘s drug use, after he claimed that the publication was “lying” in its article that claimed he was, among other things, “taking so much ketamine, a powerful anesthetic, that it was affecting his bladder, a known effect of chronic use. He took Ecstasy and psychedelic mushrooms.”

The newspaper says the Tesla and SpaceX CEO, who said earlier this week he was leaving the Trump administration after his work with DOGE, was using drugs "far more intensely than was previously known" as he became a close ally of the president near the beginning of his second term.